
AccessFox helps enterprise healthcare GTM and strategy teams identify which hospitals and health systems are becoming ready to adopt advanced therapies. Early adoption signals are public, but fragmented across hospital websites, clinical trial pages, job postings, conference activity, physician profiles, press releases, and market news. These signals often appear before formal buying intent shows up in CRM systems or static market datasets. AccessFox uses Bright Data live web infrastructure to surface current public web signals and converts them into ranked account-readiness intelligence. The app generates Account Readiness Scores, Evidence Ledgers with source links, why-now reasoning, recommended commercial actions, and outreach angles for each organization. The demo focuses on radiopharmaceutical therapy and theranostics adoption readiness, but the workflow applies broadly to complex healthcare markets such as cell therapy, proton therapy, robotic surgery, hospital-at-home, medical AI, and other advanced clinical programs. AccessFox demonstrates how live public web data can power enterprise AI workflows that turn scattered evidence into practical business action.
31 May 2026